# ::snt Many large pharmaceutical companies abandoned the technology,[24] while some biotechs re-focused on the less profitable area of vaccines, where the doses would be at lower levels and side-effects reduced."
# ::tokens ["Many", "large", "pharmaceutical", "companies", "abandoned", "the", "technology,[24", "]", "while", "some", "biotechs", "re", "-", "focused", "on", "the", "less", "profitable", "area", "of", "vaccines", ",", "where", "the", "doses", "would", "be", "at", "lower", "levels", "and", "side", "-", "effects", "reduced", ".", "\""]
# ::lemmas ["many", "large", "pharmaceutical", "company", "abandon", "the", "technology,[24", "]", "while", "some", "biotech", "re", "-", "focused", "on", "the", "less", "profitable", "area", "of", "vaccine", ",", "where", "the", "dose", "would", "be", "at", "low", "level", "and", "side", "-", "effect", "reduce", ".", "\""]
(c1-7 / contrast-01
      :ARG1 (c1-18 / abandon-01
                   :ARG0 (c1-0 / company
                               :mod (c1-23 / large)
                               :mod (c1-26 / pharmaceutical)
                               :quant (c1-12 / many))
                   :ARG1 (c1-10 / technology))
      :ARG2 (c1-19 / focus-01
                   :ARG0 (c1-8 / company
                               :mod (c1-24 / biotech)
                               :quant (c1-15 / some))
                   :ARG2 (c1-13 / area
                                :mod (c1-9 / vaccine)
                                :location-of (c1-1 / and
                                                   :op1 (c1-5 / level
                                                              :ARG1-of (c1-2 / low-04
                                                                             :ARG2-of (c1-21 / have-degree-91
                                                                                             :ARG1 c1-5
                                                                                             :ARG3 (c1-20 / more))))
                                                   :op2 (c1-11 / reduce-01
                                                               :ARG1 (c1-14 / effect-03
                                                                            :mod (c1-25 / side))))
                                :ARG1-of (c1-6 / have-degree-91
                                               :ARG2 (c1-22 / profitable-02
                                                            :ARG1 c1-13)
                                               :ARG3 (c1-4 / less)))
                   :mod (c1-27 / again))
      :ARG1-of (c1-3 / describe-01
                     :ARG0 (c1-16 / publication
                                  :ARG0-of (c1-17 / cite-01
                                                  :ARG2 24))))

# ::snt with most finding that the side-effects of mRNA insertion were too serious.[24][25] mRNA vaccines for human use have been developed and tested for the diseases rabies, Zika, cytomegalovirus, and influenza, although these mRNA vaccines have not been licensed.[26]
# ::tokens ["with", "most", "finding", "that", "the", "side", "-", "effects", "of", "mRNA", "insertion", "were", "too", "serious.[24][25", "]", "mRNA", "vaccines", "for", "human", "use", "have", "been", "developed", "and", "tested", "for", "the", "diseases", "rabies", ",", "Zika", ",", "cytomegalovirus", ",", "and", "influenza", ",", "although", "these", "mRNA", "vaccines", "have", "not", "been", "licensed.[26", "]"]
# ::lemmas ["with", "most", "finding", "that", "the", "side", "-", "effect", "of", "mrna", "insertion", "be", "too", "serious.[24][25", "]", "mrna", "vaccine", "for", "human", "use", "have", "be", "develop", "and", "test", "for", "the", "disease", "rabie", ",", "Zika", ",", "cytomegalovirus", ",", "and", "influenza", ",", "although", "these", "mrna", "vaccine", "have", "not", "be", "licensed.[26", "]"]
(c2-12 / multi-sentence
       :snt1 (c2-25 / find-01
                    :ARG1 (c2-17 / serious-02
                                 :ARG1 (c2-16 / effect-03
                                              :ARG0 (c2-4 / insert-01
                                                          :ARG1 (c2-26 / mRNA))
                                              :mod (c2-32 / side))
                                 :ARG2-of (c2-28 / have-degree-91
                                                 :ARG1 c2-16
                                                 :ARG3 (c2-9 / too)))
                    :mod (c2-21 / most))
       :snt2 (c2-24 / and
                    :op1 (c2-0 / develop-02
                               :ARG1 (c2-7 / vaccine
                                           :mod (c2-11 / mRNA))
                               :purpose (c2-30 / use-01
                                               :ARG0 (c2-3 / human)
                                               :ARG1 c2-7))
                    :op2 (c2-6 / test-01
                               :ARG1 c2-7
                               :ARG2 (c2-23 / disease
                                            :name (c2-13 / name
                                                         :op1 " rabies"))
                               :op3 (c2-20 / disease
                                           :name (c2-2 / name
                                                       :op1 "Z Zika"))
                               :op4 (c2-8 / disease
                                          :name (c2-22 / name
                                                       :op1 " cytomegalovirus"))
                               :op5 (c2-19 / disease
                                           :name (c2-5 / name
                                                       :op1 "influenza"))))
       :concession (c2-31 / license-01
                          :ARG1 (c2-27 / vaccine
                                       :mod (c2-14 / this)
                                       :mod (c2-15 / mRNA))
                          :polarity -)
       :concession (c2-18 / and
                          :op1 c2-0
                          :op2 c2-6)
       :snt3 (c2-1 / and
                   :op1 (c2-33 / publication
                               :name (c2-10 / name
                                            :op1 "24")
                               :op2-of c2-1)
                   :name (c2-29 / name
                                :op1 "25")))

# ::snt "Up until , these mRNA biotech companies had poor results testing mRNA drugs for cardiovascular, metabolic and renal diseases; selected targets for cancer; and rare diseases like CriglerNajjar syndrome,
# ::tokens ["\"", "Up", "until", ",", "these", "mRNA", "biotech", "companies", "had", "poor", "results", "testing", "mRNA", "drugs", "for", "cardiovascular", ",", "metabolic", "and", "renal", "diseases", ";", "selected", "targets", "for", "cancer", ";", "and", "rare", "diseases", "like", "CriglerNajjar", "syndrome", ","]
# ::lemmas ["\"", "up", "until", ",", "these", "mrna", "biotech", "company", "have", "poor", "result", "test", "mrna", "drug", "for", "cardiovascular", ",", "metabolic", "and", "renal", "disease", ";", "select", "target", "for", "cancer", ";", "and", "rare", "disease", "like", "CriglerNajjar", "syndrome", ","]
(c3-22 / have-03
       :ARG0 (c3-5 / company
                   :mod (c3-25 / biotech)
                   :mod (c3-9 / this))
       :ARG1 (c3-6 / thing
                   :ARG2-of (c3-10 / result-01)
                   :mod (c3-26 / poor)
                   :ARG0-of (c3-14 / test-01
                                   :ARG1 (c3-0 / drug
                                               :mod (c3-24 / protein
                                                           :name (c3-13 / name
                                                                        :op1 " mRNA")))
                                   :ARG2 (c3-21 / and
                                                :op1 (c3-20 / disease
                                                            :mod (c3-4 / heart))
                                                :op2 (c3-17 / disease
                                                            :mod (c3-12 / metabolic))
                                                :op3 (c3-8 / disease
                                                           :mod (c3-7 / renal)))))
       :time (c3-23 / until
                    :op1 (c3-3 / now))
       :purpose (c3-15 / and
                       :op1 (c3-18 / target-01
                                   :ARG1 (c3-1 / cancer))
                       :op2 (c3-16 / disease
                                   :ARG1-of (c3-11 / rare-02)
                                   :example (c3-2 / disease
                                                  :name (c3-19 / name
                                                               :op1 "CriglerNajjar"
                                                               :op2 "S Syndrome")))))
